trial

Cognitive-Behavioral Therapy in Veterans With Schizophrenia

NCTId NCT00688259
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 122 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2014-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
122 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2009-04
Primary completion
2014-09
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Supportive Therapy (ST)Cognitive Behavioral Therapy for Psychosis (CBTp)

Sponsors

VA Office of Research and DevelopmentLead Sponsor

Investigators

1
Shirley M. Glynn, PhDPrincipal Investigator

Sites

1 total
West Los Angeles, United States

Facts & assertions

4 sourced
Enrollment
122
Phase
NA
Primary Completion Date
2014-09
Status
COMPLETED
relationships
The graph out of here
drug
Supportive Therapy (ST)
drug
Cognitive Behavioral Therapy for Psychosis (CBTp)
drug
lead_sponsor
VA Office of Research and Development
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Shirley M. Glynn, PhD
person